ViviCells International Debt
| VCII Stock | USD 0.0001 0.00 0.00% |
ViviCells International holds a debt-to-equity ratio of 1.071. As of now, ViviCells International's Debt To Assets are decreasing as compared to previous years. The ViviCells International's current Total Debt To Capitalization is estimated to increase to 0.21, while Long Term Debt is projected to decrease to under 2.2 M. With a high degree of financial leverage come high-interest payments, which usually reduce ViviCells International's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
ViviCells International's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. ViviCells International's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps ViviCells Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect ViviCells International's stakeholders.
For most companies, including ViviCells International, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for ViviCells International, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, ViviCells International's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
The current Total Current Liabilities is estimated to decrease to about 684.1 K. The ViviCells International's current Change To Liabilities is estimated to increase to about (75 K)ViviCells | Build AI portfolio with ViviCells Stock |
ViviCells International Bond Ratings
ViviCells International financial ratings play a critical role in determining how much ViviCells International have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for ViviCells International's borrowing costs.| Piotroski F Score | 1 | Very Weak | View |
| Beneish M Score | (0.43) | Possible Manipulator | View |
ViviCells International Debt to Cash Allocation
As ViviCells International follows its natural business cycle, the capital allocation decisions will not magically go away. ViviCells International's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
ViviCells International currently holds 22.31 K in liabilities with Debt to Equity (D/E) ratio of 1.07, which is about average as compared to similar companies. ViviCells International has a current ratio of 4.91, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about ViviCells International's use of debt, we should always consider it together with its cash and equity.ViviCells International Total Assets Over Time
ViviCells International Assets Financed by Debt
The debt-to-assets ratio shows the degree to which ViviCells International uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.ViviCells International Debt Ratio | 19.0 |
ViviCells International Corporate Bonds Issued
Most ViviCells bonds can be classified according to their maturity, which is the date when ViviCells International has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
ViviCells Long Term Debt
Long Term Debt |
|
Understaning ViviCells International Use of Financial Leverage
Understanding the composition and structure of ViviCells International's debt gives an idea of how risky is the capital structure of the business and if it is worth investing in it. The degree of ViviCells International's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets).
| Last Reported | Projected for Next Year | ||
| Long Term Debt | 2.4 M | 2.2 M | |
| Short and Long Term Debt | 25.7 K | 23.9 K | |
| Net Debt To EBITDA | (15.95) | (16.75) | |
| Debt To Equity | 0.12 | 0.11 | |
| Debt To Assets | 0.10 | 0.19 | |
| Long Term Debt To Capitalization | 0.51 | 0.45 | |
| Total Debt To Capitalization | 0.11 | 0.21 | |
| Debt Equity Ratio | 0.12 | 0.11 | |
| Debt Ratio | 0.10 | 0.19 | |
| Cash Flow To Debt Ratio | (0.40) | (0.42) |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of ViviCells International Financial Statements. For more detail on how to invest in ViviCells Stock please use our How to Invest in ViviCells International guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is there potential for Independent Power and Renewable Electricity Producers market expansion? Will ViviCells introduce new products? Factors like these will boost the valuation of ViviCells International. If investors know ViviCells will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about ViviCells International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Revenue Growth (0.27) |
ViviCells International's market price often diverges from its book value, the accounting figure shown on ViviCells's balance sheet. Smart investors calculate ViviCells International's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since ViviCells International's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between ViviCells International's value and its price as these two are different measures arrived at by different means. Investors typically determine if ViviCells International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ViviCells International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.